Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-15 4:14 pm Purchase |
2020-12-11 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,438,032 13.500% |
8,216 (+0.24%) |
Filing History |
| 2020-11-27 4:02 pm Purchase |
2020-11-17 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 240,593 37.600% |
240,593 (New Position) |
Filing History |
| 2020-10-15 5:23 pm Purchase |
2020-10-14 | 13D | Shattuck Labs, Inc. STTK |
Redmile Group LLC | 5,619,914 13.500% |
5,619,914 (New Position) |
Filing History |
| 2020-10-15 4:08 pm Purchase |
2020-10-05 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 14,246,125 51.600% |
14,246,125 (New Position) |
Filing History |
| 2020-09-09 8:29 pm Purchase |
2020-09-09 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,429,816 14.200% |
285,816 (+9.09%) |
Filing History |
| 2020-06-17 8:26 pm Purchase |
2020-06-11 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,661,736 14.900% |
1,434,928 (+12.78%) |
Filing History |